Denise Pollard-Knight Net Worth & Insider Trades

Denise Pollard-Knight - Director, Oncomed Pharmaceuticals Inc

As of June 2, 2017

What is Denise Pollard-Knight's Net Worth?

The current estimated net worth of Oncomed Pharmaceuticals Inc's Director, Denise Pollard-Knight, is estimated to be about $70.11M . Denise Pollard-Knight owns about 1,943,509 units of Oncomed Pharmaceuticals Inc common stock. In the last 4 years at Oncomed Pharmaceuticals Inc, Denise Pollard-Knight has sold an estimated value of $4.07M worth.

What is Denise Pollard-Knight's Past Insider Trading?

Denise Pollard-Knight's largest purchase order was 2,122,807 units , worth over $1M on July 23, 2013. Denise Pollard-Knight's largest sale order was 64,561 units , worth over $1.55M on June 25, 2014. In total, Denise Pollard-Knight has made about 13 transactions over 4 years of their time at Oncomed Pharmaceuticals Inc. Denise Pollard-Knight usually trades in June, with the busiest year in 2014. The most recent transaction was a sale order of 3,799 units , worth over $82.3K on January 2, 2015.

Denise Scots-Knight

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Denise Pollard-Knight's' Mailing Address?

  • Mailing address is C/o Idenix Pharmaceuticals, Inc. 60 Hampshire Street Cambridge MA 02139 MA

Oncomed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Total
John A. Lewicki, Ph.D., 2017 $419,777 $192,925 $967,675 $167,911 $1,748,288
John A. Lewicki, Ph.D., 2016 $407,550 $141,750 - $146,718 $696,018
Paul Hastings, 2017 $551,127 $169,650 $1,857,110 $60,624 $2,638,511
Paul Hastings, 2016 $535,075 $158,760 - $264,862 $958,697
Sunil Patel, 2017 $406,117 $183,600 $939,700 $167,780 $1,697,197
Austin Gurney, Ph.D., 2017 $365,612 $154,536 $804,964 $116,996 $1,442,108
Alicia Hager, J.D., Ph.D., 2017 $347,619 $154,536 $804,964 $125,143 $1,432,262
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1302573/000156459018009577/omed-def14a_20180622.htm

What are Oncomed Pharmaceuticals Inc's Past Insider Trades?

Oncomed Pharmaceuticals Inc's most recent insider trade came on December 26, 2018 by Austin Gurney who sold 11,117 units worth $6.67K . In the last 5 years, insiders at Oncomed Pharmaceuticals Inc have sold an estimated value of $14.76M and bought an estimated value of $23.88M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Austin Gurney, See Remarks,  John A Lewicki, President and CEO,  and Alicia J Hager, SVP and General Counsel .

OncoMed Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1